Comparison of in vitro antifungal activity of itraconazole and hydroxy‐itraconazole by colorimetric MTT assay
- 1 January 1994
- Vol. 37 (1-2) , 27-33
- https://doi.org/10.1111/j.1439-0507.1994.tb00281.x
Abstract
Summary. The in vitro antifungal activities of itraconazole and its active hydroxyl metabolite, hydroxy‐itraconazole (R 63372), against Aspergillus fumigatus, Candida albicans and Cryptococcus neoformans were compared by visual assessment of growth as well as by colorimetric MTT [3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2H tetrazolium bromide] assay using microtitre plates containing four different media. Minimum inhibitory concentration (MIC) end points determined by the colorimetric MTT assay correlated well with those obtained by visual assay. The two drugs showed different MIC values depending on the medium used. The activity of itraconazole was equal to or greater than the activity of hydroxy‐itraconazole against most of the fungi tested. Both drugs showed lower MIC values against A. fumigatus*** and Cr. neoformans in brain heart infusion broth (BHI) medium than in yeast nitrogen base (YNBG) medium, Sabouraud glucose broth (SAB) or “synthetic amino acid medium, fungal” (SAAMF). However, the MIC end point of these drugs against C. albicans in BHI and SAB media was difficult to determine visually as well as by MTT assay. In C. albicans, the MTT assay method using SAAMF and YNBG media is recommended for the determination of MICs. Zusammenfassung. Die antimyzetische Aktivität von Itraconazol und seinem aktiven Metaboliten Hydroxy‐Itraconazol (R 63372) gegen Aspergillus fumigatus, Candida albicans und Cryptococcus neoformans wurde vergleichend in vier verschiedenen Medien auf Mikrotiterplatten sowohl durch visuelle Wachstumsablesung als auch im kolorimetrischen MTT‐Test [3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2H‐tetrazoliumbromid] bestimmt. Die MHK‐Endpunkte im MTT‐Test korrelierten gut mit der visuellen Ablesung. Die beiden Substanzen zeigten in Abhängigkeit von den benutzten Medien unterschiedliche MHK‐Werte. Itraconazol war gegenüber den meisten geprüften Pilzstämmen gleich oder höher aktiv als Hydroxy‐Itraconazol. Beide Substanzen ergaben niedrigere MHK‐Werte gegen A. fumigatus und Cr. neoformans in Brain‐Heart‐Infusion‐Medium (BHI) im Vergleich zu Yeast‐Nitrogen‐Base‐Medium (YNBG), Sabouraud‐Glucose‐Bouillon (SAB) und Synthetischem Aminosäuren‐Medium fungal (SAAMF). Die MHK‐Endpunkte waren bei C. albicans jedoch in BHI‐ und SAB‐Medium schwieriger visuell als im MTT‐Test abzulesen. Für C. albicans wird daher der MTT‐Test in SAAMF oder in YNBG zur MHK‐Bestimmung empfohlen.Keywords
This publication has 21 references indexed in Scilit:
- Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell linesJournal of Immunological Methods, 1993
- Synergistic interaction of miconazole and fluconazole at sub‐MIC level on Candida albicansMycoses, 1992
- Standardized susceptibility testing of fluconazole: an international collaborative studyAntimicrobial Agents and Chemotherapy, 1992
- In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric methodAntimicrobial Agents and Chemotherapy, 1992
- Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of readingAntimicrobial Agents and Chemotherapy, 1991
- The Clinical Pharmacokinetics of Itraconazole: An OverviewMycoses, 1989
- Treatment of invasive aspergillosis with itraconazoleThe American Journal of Medicine, 1989
- Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killJournal of Immunological Methods, 1989
- Antifungal susceptibility testsAntimicrobial Agents and Chemotherapy, 1987
- Itraconazole, a new triazole that is orally active in aspergillosisAntimicrobial Agents and Chemotherapy, 1984